Braskem S.A. (BAK) FinancialsBAKBraskem S.A.

Braskem S.A. (BAK) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Brazil, accounting for 71.7% of total sales, equivalent to $2.11B. Other significant revenue streams include USA and Europe and Mexico. Understanding this composition is critical for investors evaluating how BAK navigates market cycles within the Commodity Chemicals industry.

Evaluating the bottom line, Braskem S.A. maintains a gross margin of 24.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.59%, while the net margin is 15.30%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively BAK converts its operational activities into shareholder value.

In the context of the broader market, BAK competes directly with industry leaders such as KWR and HWKN. With a market capitalization of $669.45M, it holds a significant position in the sector. When comparing efficiency, BAK's gross margin of 24.48% stands against KWR's 35.53% and HWKN's 23.44%. Such benchmarking helps identify whether Braskem S.A. is trading at a premium or discount relative to its financial performance.

Braskem's financial performance shows a troubling trend, with a gross margin of only 24.48% in Q2 2026, but this follows a series of negative margins in previous quarters. The company has reported significant net income losses, including -$1.9 billion in Q4 2025, raising concerns about its profitability and sustainability.